UPFRONT SURGERY AS FIRST-LINE TREATMENT IN PATHOLOGICAL N2 NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Bertolaccini, L. [1 ]
Prisciandaro, E. [1 ]
Sedda, G. [1 ]
Girelli, L. [1 ]
Ieo, L. Spaggiari [1 ]
机构：
[1] European Inst Oncol, Thorac Surg, Milan, Italy
来源：
CHEST | 2022年 / 161卷 / 06期
关键词：
lung cancer;
D O I：
10.1016/j.chest.2021.12.345
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：315A / 315A
页数：1
相关论文
共 50 条
  • [41] First-line systemic treatment with gefitinib in stage IV non-small cell lung cancer
    Lange, T
    Müller-Tidow, C
    Serve, H
    Hoffknecht, P
    Berdel, WE
    Thomas, M
    ONCOLOGY REPORTS, 2005, 14 (06) : 1539 - 1542
  • [42] Pembrolizumab in Combination with Chemotherapy as First-Line Treatment of Advanced Non-Small Cell Lung Cancer
    Jahan, N.
    Swarup, S.
    Sultan, A.
    Naing, T.
    Mogollon-Duffo, F.
    Ball, S.
    Tun, A.
    Htut, T.
    Dash, A.
    D'Cunha, N.
    Hardwicke, F.
    Awasthi, S.
    Tijani, L.
    Thein, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S917 - S918
  • [43] BIWEEKLY CISPLATIN AND GEMCITABINE AS FIRST-LINE TREATMENT IN ADVANCED NON-SMALL CELL LUNG CANCER
    Benekli, Mustafa
    Gunaydin, Yusuf
    Inanc, Mevlude
    Ozkan, Metin
    Demirci, Ayse
    Demirci, Umut
    Suner, Ali
    Karaca, Halit
    Tonyali, Onder
    Berk, Veli
    Buyukberber, Suleyman
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S563 - S563
  • [44] First-Line Therapy of Mutated Non-Small Cell Lung Cancer: An Update
    Stoehlmacher-Williams, Jan
    ONKOLOGIE, 2012, 35 (05): : 293 - 299
  • [45] First-line combination immunotherapy for metastatic non-small cell lung cancer
    Chen, Yuh-Min
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2020, 83 (05) : 433 - 441
  • [46] Nephrotoxicity in first-line systemic therapy for non-small cell lung cancer
    Yadollahi, Sina
    Harle, Amelie
    Gorf, Lauren
    Bayne, Mike
    Geldart, Thomas
    LUNG CANCER, 2022, 165 : S36 - S37
  • [47] The Efficacy of Local Radiotherapy after Failure of First-Line Treatment for Piiia-N2 Non-Small Cell Lung Cancer
    Deng, L.
    Hui, Z.
    Men, Y.
    Kang, J.
    Sun, X.
    Wang, J.
    Wang, W.
    Bi, N.
    Zhou, Z.
    Xiao, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E145 - E146
  • [48] Risk Factors in Patients with Pathological N1 or N2 Non-Small Cell Lung Cancer
    Tokunaga, Y.
    Okamoto, T.
    Kita, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2075 - S2075
  • [49] Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N2 non-small cell lung cancer
    H Date
    K Kiura
    H Ueoka
    M Tabata
    M Aoe
    A Andou
    T Shibayama
    N Shimizu
    British Journal of Cancer, 2002, 86 : 530 - 533
  • [50] Preoperative induction chemotherapy with cisplatin and irinotecan for pathological N2 non-small cell lung cancer
    Date, H
    Kiura, K
    Ueoka, H
    Tabata, M
    Aoe, M
    Andou, A
    Shibayama, T
    Shimizu, N
    BRITISH JOURNAL OF CANCER, 2002, 86 (04) : 530 - 533
12345